NCT01198639

Brief Summary

A correlation between deep anesthesia (defined as time with Bispectral Index (BIS) lower than 45) and death within 1 yr after surgery has previously been reported. In order to confirm or refute these findings, the investigators have designed a study which compares two methods of administration for total intravenous anesthesia (propofol and remifentanil):

  • manual administration: the anesthesiologists are instructed to maintain the BIS value between 40 and 60.
  • closed loop administration: an algorithm is used to maintain the BIS value between 40 and 60. Based on previous studies, the amount of time that BIS is maintained above 40 is greater when anesthetics agents are administered using closed loop compared with manual administration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,044

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

22 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 10, 2010

Completed
3 days until next milestone

Study Start

First participant enrolled

September 13, 2010

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2015

Completed
Last Updated

February 15, 2018

Status Verified

February 1, 2018

Enrollment Period

3.4 years

First QC Date

September 9, 2010

Last Update Submit

February 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality rate during the first year following anesthesia

    one year after anesthesia

Secondary Outcomes (8)

  • conduct of anesthesia (duration of anesthesia with bispectral index < 45, bispectral index < 40, bispectral index > 60, bispectral index > 65, and burst suppression ratio)

    end of anesthesia

  • intraoperative awareness

    one month postoperatively

  • patients' satisfaction in the postanesthesia care unit (nausea, vomiting, shivering)

    end of the stay in the postanesthesia care unit

  • postoperative complication during the hospital stay (ancillary study)

    one month after anesthesia

  • major medical events during the first year following anesthesia

    one year after anesthesia

  • +3 more secondary outcomes

Study Arms (2)

manual administration of iv anesthetics

ACTIVE COMPARATOR
Device: manual administration of iv anesthetics (propofol and remifentanil) using the Toolbox platform

closed-loop administration of iv anesthetics

EXPERIMENTAL
Device: closed-loop administration of iv anesthetics (propofol and remifentanil) using the Toolbox platform

Interventions

the anesthesiologists are instructed to maintain the BIS values between 40 and 60 throughout anesthesia using target controlled infusion method

manual administration of iv anesthetics

an algorithm is used to maintain automatically the BIS values between 40 and 60

closed-loop administration of iv anesthetics

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiology patient classification status I, II and III
  • patients aged between 50 and 85 years old
  • born in France
  • surgical procedures lasting more than one hour

You may not qualify if:

  • American Society of Anesthesiology patient classification status IV
  • patients born out of France
  • pace-maker
  • surgical procedure on the skull or avoiding an adequate positioning of the bispectral index electrode dementia, history of central nervous system disease (tumor, vascular event, Parkinson disease, ...)
  • psychiatric illness (severe depression or psychosis), patients receiving a psychotropic treatment
  • allergy to propofol, soja, peanuts, or to sufentanil, remifentanil, or morphine, to a myorelaxant or to an excipient,
  • hypersensibility to sufentanil, to remifentanil, or to other derivate of fentanyl

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

CHU Victor Dupuy

Argenteuil, 95107, France

Location

CHU Besançon

Besançon, 25030, France

Location

Hôpitaux Universitaires Paris-Seine St Denis CHU Avicenne

Bobigny, 93000, France

Location

Clinique Saint Augustin

Bordeaux, France

Location

Clinique Saint Vincent de Paul

Bourgoin, France

Location

Hôpital Femme-Mère-Enfant

Bron, France

Location

CH de Chartres Louis Pasteur

Chartres, France

Location

H.I.A Percy

Clamart, France

Location

Centre Jean Perrin

Clermont-Ferrand, France

Location

Clinique des Deux Caps

Coquelles, 62231, France

Location

Clinique Fontaine-lès-Dijon

Dijon, 21121, France

Location

CHU de Grenoble

Grenoble, 38700, France

Location

Institut Hospitalier Franco Britannique

Levallois-Perret, France

Location

Institut Paoli-Calmettes

Marseille, France

Location

HIA du Val de Grace

Paris, 75005, France

Location

HEGP

Paris, 75908, France

Location

CHI Poissy/St Germain-en-Laye

Poissy, 78303, France

Location

CHU de Rouen

Rouen, 76000, France

Location

Hia Begin

Saint-Mandé, 94163, France

Location

Hôpital Foch

Suresnes, 92151, France

Location

CHU Rangueil

Toulouse, 31403, France

Location

CHU Tours

Tours, 37044, France

Location

Related Publications (5)

  • Liu N, Chazot T, Genty A, Landais A, Restoux A, McGee K, Laloe PA, Trillat B, Barvais L, Fischler M. Titration of propofol for anesthetic induction and maintenance guided by the bispectral index: closed-loop versus manual control: a prospective, randomized, multicenter study. Anesthesiology. 2006 Apr;104(4):686-95. doi: 10.1097/00000542-200604000-00012.

    PMID: 16571963BACKGROUND
  • Cantraine FR, Coussaert EJ. The first object oriented monitor for intravenous anesthesia. J Clin Monit Comput. 2000 Jan;16(1):3-10. doi: 10.1023/a:1009904805940.

    PMID: 12578088BACKGROUND
  • Lindholm ML, Traff S, Granath F, Greenwald SD, Ekbom A, Lennmarken C, Sandin RH. Mortality within 2 years after surgery in relation to low intraoperative bispectral index values and preexisting malignant disease. Anesth Analg. 2009 Feb;108(2):508-12. doi: 10.1213/ane.0b013e31818f603c.

  • Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005 Jan;100(1):4-10. doi: 10.1213/01.ANE.0000147519.82841.5E.

  • Mahr N, Bouhake Y, Chopard G, Liu N, Boichut N, Chazot T, Claveau M, Vettoretti L, Tio G, Pili-Floury S, Samain E, Besch G. Postoperative Neurocognitive Disorders After Closed-Loop Versus Manual Target Controlled-Infusion of Propofol and Remifentanil in Patients Undergoing Elective Major Noncardiac Surgery: The Randomized Controlled Postoperative Cognitive Dysfunction-Electroencephalographic-Guided Anesthetic Administration Trial. Anesth Analg. 2021 Oct 1;133(4):837-847. doi: 10.1213/ANE.0000000000005278.

Study Officials

  • Marc Fischler, MD

    Hôpital Foch

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2010

First Posted

September 10, 2010

Study Start

September 13, 2010

Primary Completion

February 20, 2014

Study Completion

February 20, 2015

Last Updated

February 15, 2018

Record last verified: 2018-02

Locations